
Phase I trial of multidrug resistance-associated protein 3-derived peptide in patients with hepatocellular carcinoma
Keywords: آنتیژن گلبول سفید انسانی; MRP3; multidrug resistance-associated protein 3; TAA; tumor-associated antigen; HLA; human leukocyte antigen; IFN; interferon; PBMC; peripheral blood mononuclear cell; HCV; hepatitis C virus; ELISPOT; enzyme-linked immunospot; Treg; regulatory T cell; MDS